{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:49:27Z","timestamp":1793116167953,"version":"4.5.0"},"reference-count":200,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>While the recent approval of amyloid-beta (A\u03b2)-clearing monoclonal antibodies (mAbs) marks a milestone in treating Alzheimer\u2019s disease (AD), their modest clinical efficacy has catalyzed a paradigm shift, underscoring the necessity of targeting complementary pathological drivers. Neuroinflammation, once considered a secondary phenomenon, is now established as a third core pathological pillar of AD, with microglia at its epicenter. This review provides a comprehensive analysis of the multifaceted role of microglia in AD pathogenesis and evaluates the rapidly evolving landscape of microglia-targeted therapeutic strategies. We first delineate the dynamic and dichotomous function of microglia, which act as a \u201cdouble-edged sword.\u201d Emerging evidence reveals a complex, three-stage functional arc: microglia are implicated in the initial seeding of A\u03b2 plaques, then transition to a neuroprotective role by containing established plaques, and finally devolve into a chronic, pro-inflammatory state that drives neurodegeneration. We then delve into the core molecular mechanisms governing this plasticity, including the pivotal Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)-APOE signaling axis, the inhibitory receptor Cluster of Differentiation 33 (CD33), and key intracellular hubs like the NLRP3 inflammasome, which directly link genetic risk factors to microglial dysregulation. Based on this mechanistic understanding, we critically evaluate diverse therapeutic strategies, ranging from suppressing neurotoxic inflammation (e.g., TNF-\u03b1 and NLRP3 inhibitors) to enhancing protective functions (e.g., TREM2 agonism and CD33 antagonism), eliminating senescent microglia (senolytics), and utilizing advanced nanoplatforms for brain-targeted delivery. Finally, we highlight the critical role of neuroinflammatory biomarkers within the emerging ATI(N) framework for enabling precision medicine. In conclusion, targeting microglia represents a vital therapeutic avenue that moves beyond amyloid-centric approaches, where a sophisticated understanding of their stage-dependent functions is paramount for developing effective immunomodulatory therapies to alter the devastating course of AD.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1818802","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:49:33Z","timestamp":1778647773000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting microglia-mediated neuroinflammation in Alzheimer\u2019s disease: mechanisms and therapeutic approaches"],"prefix":"10.3389","volume":"17","author":[{"given":"Bang-Feng","family":"Li","sequence":"first","affiliation":[{"name":"Zhuhai People\u2019s Hospital, The Affiliated Hospital of Beijing Institute of Technology","place":["Zhuhai, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhuhai People\u2019s Hospital, The Affiliated Hospital of Beijing Institute of Technology","place":["Zhuhai, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xie","sequence":"additional","affiliation":[{"name":"Zhuhai People\u2019s Hospital, The Affiliated Hospital of Beijing Institute of Technology","place":["Zhuhai, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Mo","sequence":"additional","affiliation":[{"name":"Zhuhai People\u2019s Hospital, The Affiliated Hospital of Beijing Institute of Technology","place":["Zhuhai, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Zhu","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhuhai People\u2019s Hospital, The Affiliated Hospital of Beijing Institute of Technology","place":["Zhuhai, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Meng","sequence":"additional","affiliation":[{"name":"Zhuhai People\u2019s Hospital, The Affiliated Hospital of Beijing Institute of Technology","place":["Zhuhai, Guangdong, China"]},{"name":"Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine","place":["Zhuhai, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Han","sequence":"additional","affiliation":[{"name":"Zhuhai People\u2019s Hospital, The Affiliated Hospital of Beijing Institute of Technology","place":["Zhuhai, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-He","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhuhai People\u2019s Hospital, The Affiliated Hospital of Beijing Institute of Technology","place":["Zhuhai, Guangdong, China"]},{"name":"Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine","place":["Zhuhai, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jun","family":"Peng","sequence":"additional","affiliation":[{"name":"Zhuhai People\u2019s Hospital, The Affiliated Hospital of Beijing Institute of Technology","place":["Zhuhai, Guangdong, China"]},{"name":"Department of Medical Imaging, Zhuhai People\u2019s Hospital (The Affiliated Hospital of Beijing Institute of Technology, Zhuhai Clinical Medical College of Jinan University)","place":["Zhuhai, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer\u2019s disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"B7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.59566\/IJBS.2006.2196","article-title":"Alois Alzheimer: A hundred years after the discovery of the eponymous disorder","volume":"2","author":"Tagarelli","year":"2006","journal-title":"Int J BioMed Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s13311-021-01179-3","article-title":"Microglia in Alzheimer\u2019s disease: A key player in the transition between homeostasis and pathogenesis","volume":"19","author":"McFarland","year":"2022","journal-title":"Neurotherapeutics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in alzheimer disease","volume":"25","author":"Heneka","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.20517\/2347-8659.2020.60","article-title":"Pathways linking Alzheimer\u2019s disease risk genes expressed highly in microglia","volume":"8","author":"Hodges","year":"2021","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00687-4","article-title":"Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer\u2019s disease","volume":"19","author":"Wang","year":"2024","journal-title":"Mol Neurodegener"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006082","article-title":"CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease","volume":"91","author":"Janelidze","year":"2018","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-1-14","article-title":"Microglia and neuroinflammation: A pathological perspective","volume":"1","author":"Streit","year":"2004","journal-title":"J Neuroinflamm"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat0474","article-title":"Microglia and early brain development: An intimate journey","volume":"362","author":"Thion","year":"2018","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat Neurosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12264-022-01013-6","article-title":"Novel microglia-based therapeutic approaches to neurodegenerative disorders","volume":"39","author":"Zhang","year":"2023","journal-title":"Neurosci Bull"},{"key":"B17","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1038\/s41467-024-54779-w","article-title":"Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer\u2019s disease","volume":"15","author":"Balig\u00e1cs","year":"2024","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578342","article-title":"Microglia and amyloid plaque formation in Alzheimer\u2019s disease \u2013 Evidence, possible mechanisms, and future challenges","volume":"390","author":"Fruhw\u00fcrth","year":"2024","journal-title":"J Neuroimmunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.10.007","article-title":"Microglia-mediated neuroprotection, TREM2, and Alzheimer\u2019s disease: Evidence from optical imaging","volume":"83","author":"Condello","year":"2018","journal-title":"Biol Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","article-title":"Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques","volume":"6","author":"Condello","year":"2015","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00913-5","article-title":"Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques","volume":"22","author":"Huang","year":"2021","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature18283","article-title":"A complement\u2013microglial axis drives synapse loss during virus-induced memory impairment","volume":"534","author":"Vasek","year":"2016","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: A field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential roles of M1 and M2 microglia in neurodegenerative diseases","volume":"53","author":"Tang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2009.02.003","article-title":"Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-\u03b2","volume":"210","author":"Michelucci","year":"2009","journal-title":"J Neuroimmunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: Do M1 and M2 microglia exist","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat Neurosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer\u2019s disease","volume":"570","author":"Mathys","year":"2019","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.01.010","article-title":"Microglia heterogeneity in the single-cell era","volume":"30","author":"Masuda","year":"2020","journal-title":"Cell Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","article-title":"High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease","volume":"48","author":"Mrdjen","year":"2018","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041366","article-title":"Microglia in health and diseases: Integrative hubs of the central nervous system (CNS)","volume":"16","author":"Sierra","year":"2024","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: A universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0057-5","article-title":"Microglial signatures and their role in health and disease","volume":"19","author":"Butovsky","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/biology12101307","article-title":"Microglia and astrocytes in amyotrophic lateral sclerosis: Disease-associated states, pathological roles, and therapeutic potential","volume":"12","author":"You","year":"2023","journal-title":"Biology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107843","article-title":"Alzheimer\u2019s patient microglia exhibit enhanced aging and unique transcriptional activation","volume":"31","author":"Srinivasan","year":"2020","journal-title":"Cell Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","article-title":"Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain","volume":"23","author":"Marschallinger","year":"2020","journal-title":"Nat Neurosci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/biom13060912","article-title":"The Janus-faced role of lipid droplets in aging: Insights from the cellular perspective","volume":"13","author":"Bresgen","year":"2023","journal-title":"Biomolecules"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2024.01092","article-title":"Association between abnormal lipid metabolism and Alzheimer\u2019s disease: New research has revealed significant findings on the APOE4 genotype in microglia","volume":"18","author":"Hu","year":"2024","journal-title":"Biosci Trends"},{"key":"B42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12979-022-00300-0","article-title":"Different phenotypes of microglia in animal models of Alzheimer disease","volume":"19","author":"Wei","year":"2022","journal-title":"Immun Ageing"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","article-title":"The major risk factors for Alzheimer\u2019s disease: Age, sex, and genes modulate the microglia response to A\u03b2 plaques","volume":"27","author":"Frigerio","year":"2019","journal-title":"Cell Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.12.066","article-title":"Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer\u2019s disease not evident in mouse models","volume":"22","author":"Friedman","year":"2018","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2009.2","article-title":"Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer\u2019s disease","volume":"1","author":"Rodr\u00edguez","year":"2010","journal-title":"Cell Death Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","article-title":"Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model","volume":"10","author":"Spangenberg","year":"2019","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104956","article-title":"Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies","volume":"142","author":"Casali","year":"2020","journal-title":"Neurobiol Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1308345","article-title":"New insight on microglia activation in neurodegenerative diseases and therapeutics","volume":"17","author":"Xu","year":"2023","journal-title":"Front Neurosci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.896852","article-title":"Functional and phenotypic diversity of microglia: Implication for microglia-based therapies for Alzheimer\u2019s disease","volume":"14","author":"Xu","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.07.001","article-title":"Nitration of tyrosine 10 critically enhances amyloid \u03b2 aggregation and plaque formation","volume":"71","author":"Kummer","year":"2011","journal-title":"Neuron"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1391517","article-title":"The emerging role of brain neuroinflammatory responses in Alzheimer\u2019s disease","volume":"16","author":"Amelimojarad","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv081","article-title":"Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain","volume":"138","author":"Maphis","year":"2015","journal-title":"Brain"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020279","article-title":"Beyond amyloid and tau: The critical role of microglia in Alzheimer\u2019s disease therapeutics","volume":"13","author":"Dias","year":"2025","journal-title":"Biomedicines"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2347-23.2024","article-title":"Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer\u2019s disease and multiple sclerosis","volume":"44","author":"Etxeberria","year":"2024","journal-title":"J Neurosci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13024-025-00867-4","article-title":"Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: Current status and future directions","volume":"20","author":"Noh","year":"2025","journal-title":"Mol Neurodegener"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ibneur.2025.05.005","article-title":"Effect of neuroinflammation on the progression of Alzheimer\u2019s disease and its significant ramifications for novel anti-inflammatory treatments","volume":"18","author":"Kamila","year":"2025","journal-title":"IBRO Neurosci Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.109","article-title":"Neuroinflammation, its role in Alzheimer\u2019s disease and therapeutic strategies","volume":"10","author":"Kiraly","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081207","article-title":"The functions and phenotypes of microglia in Alzheimer\u2019s disease","volume":"12","author":"Fujikawa","year":"2023","journal-title":"Cells"},{"key":"B60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13024-018-0247-7","article-title":"Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"13","author":"Zhong","year":"2018","journal-title":"Mol Neurodegener"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1575453","article-title":"The roles of microglia and astrocytes in neuroinflammation of Alzheimer\u2019s disease","volume":"19","author":"Han","year":"2025","journal-title":"Front Neurosci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M402034200","article-title":"Tumor necrosis factor-\u03b1, interleukin-1\u03b2, and interferon-\u03b3 stimulate \u03b3-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway *","volume":"279","author":"Liao","year":"2004","journal-title":"J Biol Chem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170065","article-title":"Genetic deletion of tumor necrosis factor-\u03b1 attenuates amyloid-\u03b2 production and decreases amyloid plaque formation and glial response in the 5XFAD model of Alzheimer\u2019s disease","volume":"60","author":"Paouri","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","article-title":"What is the evidence that tau pathology spreads through prion-like propagation","volume":"5","author":"Mudher","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat Neurosci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.277061","article-title":"Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease *","volume":"287","author":"Saman","year":"2012","journal-title":"J Biol Chem"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1554398","article-title":"The dual role of microglia in Alzheimer\u2019s disease: From immune regulation to pathological progression","volume":"17","author":"He","year":"2025","journal-title":"Front Aging Neurosci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2017","journal-title":"J Cell Biol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40035-025-00515-3","article-title":"Roles of TREM2 in alzheimer\u2019s disease","volume":"14","author":"Qi","year":"2025","journal-title":"Transl Neurodegener"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1550893","article-title":"TREM2+ macrophages: A key role in disease development","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00247-8","article-title":"Stimulation of TREM2 with agonistic antibodies\u2014an emerging therapeutic option for Alzheimer\u2019s disease","volume":"22","author":"Schlepckow","year":"2023","journal-title":"Lancet Neurol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1576020","article-title":"The potential and challenges of TREM2-targeted therapy in Alzheimer\u2019s disease: Insights from the INVOKE-2 study","volume":"17","author":"Ma","year":"2025","journal-title":"Front Aging Neurosci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157057","article-title":"TREM2 in neurodegenerative disorders: Mutation spectrum, pathophysiology, and therapeutic targeting","volume":"26","author":"Yang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/alz.089318","article-title":"Pharmacological and functional characterization of the first small molecule TREM2 agonist, VG-3927, for the treatment of Alzheimer\u2019s disease","volume":"20","author":"Mirescu","year":"2024","journal-title":"Alzheimers Dement"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103057","article-title":"A natural small molecule aspidosperma-type alkaloid, hecubine, as a new TREM2 activator for alleviating lipopolysaccharide-induced neuroinflammation in vitro and in vivo","volume":"70","author":"Li","year":"2024","journal-title":"Redox Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-024-01620-8","article-title":"Identification of senescent, TREM2-expressing microglia in aging and Alzheimer\u2019s disease model mouse brain","volume":"27","author":"Rachmian","year":"2024","journal-title":"Nat Neurosci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","article-title":"TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease","volume":"103","author":"Griciuc","year":"2019","journal-title":"Neuron"},{"key":"B79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jnc.15349","article-title":"CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer\u2019s disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion","volume":"158","author":"Butler","year":"2021","journal-title":"J Neurochem"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/biom15111629","article-title":"Microglia-mediated phagocytosis in Alzheimer\u2019s disease: Mechanisms, heterogeneity, and therapeutic insights","volume":"15","author":"Hassan","year":"2025","journal-title":"Biomolecules"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070833","article-title":"Targeting microglia in Alzheimer\u2019s disease: Pathogenesis and potential therapeutic strategies","volume":"14","author":"Sun","year":"2024","journal-title":"Biomolecules"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nature17630","article-title":"TAM receptors regulate multiple features of microglial physiology","volume":"532","author":"Fourgeaud","year":"2016","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109791","article-title":"An insight into the TAM system in Alzheimer\u2019s disease","volume":"116","author":"Zhou","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.7150\/thno.26164","article-title":"Jujuboside A promotes A\u03b2 clearance and ameliorates cognitive deficiency in Alzheimer\u2019s disease through activating Axl\/HSP90\/PPAR\u03b3 pathway","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115559","article-title":"Ganoderic acid A promotes amyloid-\u03b2 clearance (in vitro) and ameliorates cognitive deficiency in Alzheimer\u2019s disease (mouse model) through autophagy induced by activating Axl","volume":"22","author":"Qi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41582-025-01162-y","article-title":"Microglial phagocytosis in Alzheimer disease","volume":"22","author":"Brown","year":"2026","journal-title":"Nat Rev Neurol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.fawpar.2025.e00284","article-title":"CX3CL1\/CX3CR1 involved modulation of microglial activation and eosinophilic meningoencephalitis in angiostrongyliasis","volume":"41","author":"Lai","year":"2025","journal-title":"Food Waterborne Parasitol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1678159","article-title":"CX3CR1: A potential microglia-specific PET imaging target in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"16","author":"Yang","year":"2025","journal-title":"Front Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182238","article-title":"The intracellular domain of CX3CL1 regulates adult neurogenesis and Alzheimer\u2019s amyloid pathology","volume":"216","author":"Fan","year":"2019","journal-title":"J Exp Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1333-19.2019","article-title":"Activated CX3CL1\/Smad2 signals prevent neuronal loss and Alzheimer\u2019s tau pathology-mediated cognitive dysfunction","volume":"40","author":"Fan","year":"2020","journal-title":"J Neurosci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02780","article-title":"Heterozygous CX3CR1 deficiency in microglia restores neuronal \u03b2-amyloid clearance pathways and slows progression of Alzheimer\u2019s like-disease in PS1-APP mice","volume":"10","author":"Hickman","year":"2019","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-022-00545-9","article-title":"CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u2019s disease","volume":"17","author":"Puntambekar","year":"2022","journal-title":"Mol Neurodegener"},{"key":"B93","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12974-018-1310-6","article-title":"Genetically enhancing the expression of chemokine domain of CX3CL1 fails to prevent tau pathology in mouse models of tauopathy","volume":"15","author":"Bemiller","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B94","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-017-0200-1","article-title":"Absence of CX3CR1 impairs the internalization of tau by microglia","volume":"12","author":"Bol\u00f3s","year":"2017","journal-title":"Mol Neurodegener"},{"key":"B95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/mr\/road004","article-title":"Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate","volume":"34","author":"Tanaka","year":"2023","journal-title":"Mod Rheumatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8090918","article-title":"CX3CL1\/CX3CR1 in Alzheimer\u2019s disease: A target for neuroprotection","volume":"2016","author":"Chen","year":"2016","journal-title":"BioMed Res Int"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2012.12.011","article-title":"Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy","volume":"34","author":"Nash","year":"2013","journal-title":"Neurobiol Aging"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.845185","article-title":"The role of NLRP3 inflammasome in Alzheimer\u2019s disease and potential therapeutic targets","volume":"13","author":"Liang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1109938","article-title":"The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors","volume":"13","author":"Zhan","year":"2023","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: A review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12030722","article-title":"Inhibiting NLRP3 inflammasome activation by CY-09 helps to restore cerebral glucose metabolism in 3\u00d7Tg-AD mice","volume":"12","author":"Han","year":"2023","journal-title":"Antioxidants"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.805169","article-title":"Crosstalk between the NLRP3 inflammasome\/ASC speck and amyloid protein aggregates drives disease progression in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"15","author":"Hulse","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1206948","article-title":"The role of pyroptosis in cognitive impairment","volume":"17","author":"Yang","year":"2023","journal-title":"Front Neurosci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S478479","article-title":"The relationship between Alzheimer\u2019s disease and pyroptosis and the intervention progress of traditional Chinese medicine","volume":"17","author":"Zhang","year":"2024","journal-title":"Int J Gen Med"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-022-02528-y","article-title":"Pyroptosis in Alzheimer\u2019s disease: Cell type-specific activation in microglia, astrocytes and neurons","volume":"145","author":"Moonen","year":"2023","journal-title":"Acta Neuropathol (Berl)"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01370","article-title":"Recent progress and prospects of small molecules for NLRP3 inflammasome inhibition","volume":"66","author":"Li","year":"2023","journal-title":"J Med Chem"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127186","article-title":"Synthesis and evaluation of NLRP3-inhibitory sulfonylurea [11C]MCC950 in healthy animals","volume":"30","author":"Hill","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2009680117","article-title":"The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"117","author":"Lonnemann","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J Exp Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.123.002013","article-title":"Reversal of high fat diet-induced obesity, systemic inflammation, and astrogliosis by the NLRP3 inflammasome inhibitors NT-0249 and NT-0796","volume":"388","author":"Thornton","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411747","article-title":"The P2X7 receptor, a multifaceted receptor in Alzheimer\u2019s disease","volume":"24","author":"Ronning","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110265","article-title":"Genetic variations in the P2X7 receptor: Opportunities and challenges for drug development","volume":"26","author":"Cheah","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.645244","article-title":"The P2X7 receptor in microglial cells modulates the endolysosomal axis, autophagy, and phagocytosis","volume":"15","author":"Campagno","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1097\/01.jnen.0000240470.97295.d3","article-title":"Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-\u03b2 peptide-treated microglia and in peptide-injected rat hippocampus","volume":"65","author":"McLarnon","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"B119","first-page":"2024.02.28.582443","article-title":"Hippocampal purinergic P2X7 receptor level is increased in Alzheimer\u2019s disease patients, and associated with amyloid and tau pathologies","volume-title":"bioRxiv","author":"Maschio","year":"2024"},{"key":"B120","first-page":"2022.05.12.491601","article-title":"Microglial P2X4 receptors promote ApoE degradation and cognitive deficits in Alzheimer disease","volume-title":"bioRxiv","author":"Hua","year":"2022"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037896","article-title":"Anti-prion activity of brilliant blue G","volume":"7","author":"Iwamaru","year":"2012","journal-title":"PloS One"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.2174\/1567205013666160208142456","article-title":"Oral triphenylmethane food dye analog, brilliant blue G, prevents neuronal loss in APPSwDI\/NOS2-\/- mouse model","volume":"13","author":"Irwin","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1450704","article-title":"Unlocking the therapeutic potential of P2X7 receptor: A comprehensive review of its role in neurodegenerative disorders","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-025-00825-0","article-title":"Decoding microglial immunometabolism: A new frontier in Alzheimer\u2019s disease research","volume":"20","author":"Jung","year":"2025","journal-title":"Mol Neurodegener"},{"key":"B125","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","article-title":"Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease","volume":"34","author":"Pan","year":"2022","journal-title":"Cell Metab"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114488","article-title":"Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer\u2019s progression","volume":"43","author":"Codocedo","year":"2024","journal-title":"Cell Rep"},{"key":"B127","first-page":"2023.11.11.566270","article-title":"Therapeutic targeting of immunometabolism in Alzheimer\u2019s disease reveals a critical reliance on hexokinase 2 dosage on microglial activation and disease progression","volume-title":"bioRxiv","author":"Codocedo","year":"2023"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.4103\/1673-5374.367842","article-title":"Microglial metabolic reconfiguration provides a new strategy for the treatment of Alzheimer\u2019s disease","volume":"18","author":"Leng","year":"2023","journal-title":"Neural Regener Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114148","article-title":"TEPP-46 inhibits glycolysis to promote M2 polarization of microglia after ischemic stroke","volume":"149","author":"Xia","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s42003-021-02259-y","article-title":"Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer\u2019s disease","volume":"4","author":"Guillot-Sestier","year":"2021","journal-title":"Commun Biol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia","volume":"628","author":"Haney","year":"2024","journal-title":"Nature"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.immuni.2025.04.029","article-title":"Amyloid-\u03b2 induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer\u2019s disease","volume":"58","author":"Prakash","year":"2025","journal-title":"Immunity"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq6038","article-title":"Reducing microglial lipid load enhances \u03b2 amyloid phagocytosis in an Alzheimer\u2019s disease mouse model","volume":"11","author":"Wu","year":"2025","journal-title":"Sci Adv"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023418118","article-title":"Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading","volume":"118","author":"Xu","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13024-023-00648-x","article-title":"Oleoylethanolamide facilitates PPAR\u03b1 and TFEB signaling and attenuates A\u03b2 pathology in a mouse model of Alzheimer\u2019s disease","volume":"18","author":"Comerota","year":"2023","journal-title":"Mol Neurodegener"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1065183","article-title":"Microglial autophagy in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.01.008","article-title":"Impairment of the autophagy\u2013lysosomal pathway in Alzheimer\u2019s diseases: Pathogenic mechanisms and therapeutic potential","volume":"12","author":"Zhang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B138","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/cns.13985","article-title":"The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases","volume":"29","author":"Jiao","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2022.0927","article-title":"Novel insight into functions of transcription factor EB (TFEB) in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"14","author":"Yang","year":"2023","journal-title":"Aging Dis"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115081","article-title":"Curcumin analog C1 activates autophagy through a TFEB-dependent mechanism to protect sensory hair cells from oxidative stress in C57BL\/6 mice with age-related hearing loss","volume":"161","author":"He","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2046437","article-title":"Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease","volume":"18","author":"Zhang","year":"2022","journal-title":"Autophagy"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/srep38586","article-title":"SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy","volume":"6","author":"Mayer","year":"2016","journal-title":"Sci Rep"},{"key":"B143","first-page":"2025.09.04.674092","article-title":"Inhibition of autophagy-lysosomal function exacerbates microglial and monocyte lipid metabolism reprograming and dysfunction after brain injury","volume-title":"bioRxiv","author":"Mehrabani-Tabari","year":"2025"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073330","article-title":"Alzheimer\u2019s disease pathogenesis: Role of autophagy and mitophagy focusing in microglia","volume":"22","author":"Eshraghi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2017.1293766","article-title":"The role of NLRP3-CASP1 in inflammasome-mediated neuroinflammation and autophagy dysfunction in manganese-induced, hippocampal-dependent impairment of learning and memory ability","volume":"13","author":"Wang","year":"2017","journal-title":"Autophagy"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415777","article-title":"Key characteristics and development of psychoceuticals: A review","volume":"23","author":"Cano","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11070421","article-title":"Trehalose reduces the secreted beta-amyloid levels in primary neurons independently of autophagy induction","volume":"11","author":"Benito-Cuesta","year":"2021","journal-title":"Metabolites"},{"key":"B148","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41421-018-0011-8","article-title":"Dual extra-retinal origins of microglia in the model of retinal microglia repopulation","volume":"4","author":"Huang","year":"2018","journal-title":"Cell Discov"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1283711","article-title":"Limitations of PLX3397 as a microglial investigational tool: Peripheral and off-target effects dictate the response to inflammation","volume":"14","author":"Claeys","year":"2023","journal-title":"Front Immunol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/brain\/awv379","article-title":"Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology","volume":"139","author":"Olmos-Alonso","year":"2016","journal-title":"Brain"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.969127","article-title":"Restorative therapy using microglial depletion and repopulation for central nervous system injuries and diseases","volume":"13","author":"Shi","year":"2022","journal-title":"Front Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70565","article-title":"Repopulating microglia suppress peripheral immune cell infiltration to promote poststroke recovery","volume":"31","author":"Shi","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2025.1066","article-title":"Microglial replacement reverses age-associated epigenetic modifications despite accelerating epigenetic age","volume":"17","author":"Arbaizar-Rovirosa","year":"2025","journal-title":"Aging Dis"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz241","article-title":"CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice","volume":"142","author":"Mancuso","year":"2019","journal-title":"Brain"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00440-9","article-title":"Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model","volume":"16","author":"Clayton","year":"2021","journal-title":"Mol Neurodegener"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2402-19.2020","article-title":"Microglial depletion with CSF1R inhibitor during chronic phase of experimental traumatic brain injury reduces neurodegeneration and neurological deficits","volume":"40","author":"Henry","year":"2020","journal-title":"J Neurosci"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100204","article-title":"Drug delivery strategies to cross the blood-brain barrier in Alzheimer\u2019s disease: A comprehensive review on three promising strategies","volume":"12","author":"de Koning","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"B158","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12035-025-05417-z","article-title":"Targeted nanoparticles for drug delivery across the blood\u2013brain barrier in early and late stages of Alzheimer\u2019s disease: A review","volume":"63","author":"Kochman","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202420547","article-title":"A self-reinforced \u201cmicroglia energy modulator\u201d for synergistic amyloid-\u03b2 clearance in Alzheimer\u2019s disease model","volume":"137","author":"Ma","year":"2025","journal-title":"Angew Chem"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c08317","article-title":"Modulating amyloid pathology\u2013neural hyperexcitability crosstalk for Alzheimer\u2019s disease therapy","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031370","article-title":"Mannose ligands for mannose receptor targeting","volume":"25","author":"Paurevi\u0107","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2024.05.006","article-title":"Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer\u2019s disease","volume":"119","author":"Badr","year":"2024","journal-title":"Brain Behav Immun"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.5c09843","article-title":"Engineered stem cell membrane-coated nanodrugs for targeted therapy of Alzheimer\u2019s disease","volume":"17","author":"Sha","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.01.015","article-title":"Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer\u2019s disease","volume":"15","author":"Wei","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309225","article-title":"Nanoparticle-mediated delivery of anti-PU.1 siRNA via localized intracisternal administration reduces neuroinflammation","volume":"36","author":"Ralvenius","year":"2024","journal-title":"Adv Mater"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-024-01103-1","article-title":"Alzheimer\u2019s disease: Combination therapies and clinical trials for combination therapy development","volume":"38","author":"Cummings","year":"2024","journal-title":"CNS Drugs"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3390\/cells14040264","article-title":"Immune modulation in Alzheimer\u2019s disease: From pathogenesis to immunotherapy","volume":"14","author":"Balkhi","year":"2025","journal-title":"Cells"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199529","article-title":"Anti-amyloid therapies for Alzheimer\u2019s disease: Progress, pitfalls, and the path ahead","volume":"26","author":"Papaliagkas","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1708565","article-title":"GLP-1 receptor agonists in Alzheimer\u2019s and Parkinson\u2019s disease: Endocrine pathways, clinical evidence, and future directions","volume":"16","author":"Gandhi","year":"2025","journal-title":"Front Endocrinol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3233\/jad-210400","article-title":"A novel inhibitor targeting NLRP3 inflammasome reduces neuropathology and improves cognitive function in Alzheimer\u2019s disease transgenic mice","volume":"82","author":"Kuwar","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0467-9","article-title":"NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer\u2019s disease","volume":"55","author":"Yin","year":"2018","journal-title":"Mol Neurobiol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1201982","article-title":"Microglia in Alzheimer\u2019s disease: Pathogenesis, mechanisms, and therapeutic potentials","volume":"15","author":"Miao","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"B174","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12987-025-00737-7","article-title":"Transferrin receptor-binding blood-brain barrier shuttle enhances brain delivery and plaque-clearing efficacy of a therapeutic anti-A\u03b2 antibody","volume":"22","author":"Vega","year":"2025","journal-title":"Fluids Barriers CNS"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100214","article-title":"Bispecific brain-penetrant antibodies for treatment of Alzheimer\u2019s disease","volume":"12","author":"Sehlin","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24282","article-title":"Is microglial dystrophy a form of cellular senescence? An analysis of senescence markers in the aged human brain","volume":"71","author":"Neumann","year":"2023","journal-title":"Glia"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14860","article-title":"Microglia and the aging brain: Are senescent microglia the key to neurodegeneration","volume":"151","author":"Angelova","year":"2019","journal-title":"J Neurochem"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00483-8","article-title":"The metabolic roots of senescence: Mechanisms and opportunities for intervention","volume":"3","author":"Wiley","year":"2021","journal-title":"Nat Metab"},{"key":"B179","year":""},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70051","article-title":"The role of glial cell senescence in Alzheimer\u2019s disease","volume":"169","author":"Alshaebi","year":"2025","journal-title":"J Neurochem"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106711","article-title":"Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model","volume":"202","author":"Yao","year":"2024","journal-title":"Neurobiol Dis"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-019-0372-9","article-title":"Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model","volume":"22","author":"Zhang","year":"2019","journal-title":"Nat Neurosci"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1227705","article-title":"Senolytic therapy is neuroprotective and improves functional outcome long-term after traumatic brain injury in mice","volume":"17","author":"Wang","year":"2023","journal-title":"Front Neurosci"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0543-y","article-title":"Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline","volume":"562","author":"Bussian","year":"2018","journal-title":"Nature"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13296","article-title":"Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice","volume":"20","author":"Ogrodnik","year":"2021","journal-title":"Aging Cell"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-25-01672","article-title":"Retiring the sentinels: Could clearing senescent microglia be the answer to extending brain healthspan","volume":"21","author":"Ferr\u00e3o","year":"2026","journal-title":"Neural Regener Res"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12832","article-title":"Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice","volume":"17","author":"Elmore","year":"2018","journal-title":"Aging Cell"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1088-4","article-title":"CD22 blockade restores homeostatic microglial phagocytosis in ageing brains","volume":"568","author":"Pluvinage","year":"2019","journal-title":"Nature"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00643-4","article-title":"Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to \u03b2-amyloid clearance","volume":"4","author":"Leng","year":"2022","journal-title":"Nat Metab"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00402-3","article-title":"Emerging role of senescent microglia in brain aging-related neurodegenerative diseases","volume":"13","author":"Rim","year":"2024","journal-title":"Transl Neurodegener"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01240-0","article-title":"A TREM2-activating antibody with a blood\u2013brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models","volume":"26","author":"van Lengerich","year":"2023","journal-title":"Nat Neurosci"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA\u2010AA research framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","volume":"17","author":"Hampel","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S357558","article-title":"Neuroinflammation as a potential therapeutic target in Alzheimer\u2019s disease","volume":"17","author":"Liu","year":"2022","journal-title":"Clin Interv Aging"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.54","article-title":"Neuroinflammation biomarkers in the AT(N) framework across the Alzheimer\u2019s disease continuum","volume":"10","author":"Bieger","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13862","article-title":"CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer\u2019s disease","volume":"20","author":"Warmenhoven","year":"2024","journal-title":"Alzheimers Dement"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2010.1310","article-title":"YKL-40 expression in traumatic brain injury: An initial analysis","volume":"27","author":"Bonneh-Barkay","year":"2010","journal-title":"J Neurotrauma"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1177\/25424823251341870","article-title":"Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer\u2019s disease","volume":"9","author":"Fakorede","year":"2025","journal-title":"J Alzheimers Dis Rep"},{"key":"B200","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/cpt.2554","article-title":"Biomarker qualification at the European Medicines Agency: A review of biomarker qualification procedures from 2008 to 2020","volume":"112","author":"Bakker","year":"2022","journal-title":"Clin Pharmacol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1818802\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:49:41Z","timestamp":1778647781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1818802\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":200,"alternative-id":["10.3389\/fimmu.2026.1818802"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1818802","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1818802"}}